Open Access Pre-publication history

Worse prognosis of KRAS c.35 G > A mutant metastatic colorectal cancer (MCRC) patients treated with intensive triplet chemotherapy plus bevacizumab (FIr-B/FOx)

Gemma Bruera, Katia Cannita, Daniela Di Giacomo, Aude Lamy, Thierry Frébourg, Jean Christophe Sabourin, Mario Tosi, Edoardo Alesse, Corrado Ficorella and Enrico Ricevuto*

BMC Medicine 2013, 11:59  doi:10.1186/1741-7015-11-59

Pre-publication versions of this article and reviewers' reports

Original Submission - Version 1 Manuscript 29 Sep 2012
Resubmission - Version 2 Manuscript Author's comment 29 Sep 2012
Reviewer's Report raffaele palmirotta 05 Nov 2012
Reviewer's Report Takayuki Yoshino 10 Nov 2012
Reviewer's Report Paolo Correale 05 Dec 2012
Resubmission - Version 3 Manuscript Author's comment 14 Dec 2012
Resubmission - Version 4 Manuscript Author's comment 12 Jan 2013
Editorial acceptance 14 Feb 2013
Published 04 Mar 2013